FDA Approves Brekiya (dihydroergotamine mesylate) for Acute Migraine & Cluster Headaches in Adults

FDA Approves Brekiya (dihydroergotamine mesylate) for Acute Migraine & Cluster Headaches in Adults

FDA Grants Accelerated Approval to Avmapki Fakzynja Co-Pack (avutometinib capsules/defactinib)

FDA Approves Ctexli (chenodiol) for Cerebrotendinous Xanthomatosis

FDA Approves Romvimza (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor

FDA Approves Emblaveo (aztreonam & avibactam) for Adults With Complicated Intra-Abdominal Infections

FDA Approves Onapgo (apomorphine hydrochloride) for Advanced Parkinson’s Disease

FDA Approves Subvenite (lamotrigine) Oral Suspension for Epilepsy and Bipolar Disorder

FDA Approves Inluriyo (imlunestrant) for Adults with Mutated Advanced or Metastatic Breast Cancer.

FDA Approves Palsonify (paltusotine) for the Treatment of Acromegaly in Adults

FDA Approves Bondlido (lidocaine topical system) for the Treatment of Post-Herpetic Neuralgia

FDA Approves Bondlido (lidocaine topical system) for the Treatment of Post-Herpetic Neuralgia

FDA Approves Zusduri (mitomycin) for Non-Muscle Invasive Bladder Cancer